← Back to Search

TMS Brain Signal Measurement in Healthy Subjects

N/A
Recruiting
Led By David J Levinthal, MD PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up multiple study sessions spanning up to 12 months
Awards & highlights

Study Summary

This trial studies how to non-invasively measure brain signals in the stomach using magnetic stimulation and brain signals.

Who is the study for?
This trial is for healthy individuals interested in participating in a study to understand how the brain can influence stomach functions. Specific eligibility criteria are not provided, but typically participants should be free from any medical conditions that could interfere with the study.Check my eligibility
What is being tested?
The study is testing a non-invasive brain stimulation technique called Transcranial Magnetic Stimulation (TMS) to see how it affects signals going to the stomach. The goal is to find out the best settings and areas of the brain to use for this method.See study design
What are the potential side effects?
TMS may cause mild headaches or scalp discomfort at the site of stimulation, lightheadedness, or tingling sensations. It's generally considered safe with no serious side effects when performed correctly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~multiple study sessions spanning up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and multiple study sessions spanning up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in GEP hotspot location
Change in optimal stimulation parameters at GEP hotspot
Secondary outcome measures
Effect of neuromodulation
Effect of satiety

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment1 Intervention
All participants

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,723 Previous Clinical Trials
16,343,001 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,341 Previous Clinical Trials
649,434 Total Patients Enrolled
David J Levinthal, MD PhDPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
110 Total Patients Enrolled

Media Library

All participants Clinical Trial Eligibility Overview. Trial Name: NCT05924009 — N/A
Healthy Subjects Research Study Groups: All participants
Healthy Subjects Clinical Trial 2023: All participants Highlights & Side Effects. Trial Name: NCT05924009 — N/A
All participants 2023 Treatment Timeline for Medical Study. Trial Name: NCT05924009 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment accommodate participants who exceed the age of twenty?

"This research project is inviting volunteers aged 21 and older but younger than 60 to participate."

Answered by AI

Is enrollment open to the public for this clinical experiment?

"According to clinicaltrials.gov, this particular medical study has ended its participant search after being posted on July 1st 2023 and last updated on June 26th 2023. Fortunately, there are 792 other trials that are still taking in applicants at the moment."

Answered by AI

For whom is this study most appropriate?

"Eligible candidates for this clinical trial must be aged between 21 and 60, have no medical complications, and be one of the total 155 openings."

Answered by AI
~103 spots leftby Jul 2026